TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
+1.82%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$113B
AUM Growth
-$291M
(-0.26%)
Cap. Flow
-$48.7M
Cap. Flow
% of AUM
-0.04%
Top 10 Holdings %
Top 10 Hldgs %
26.07%
Holding
1,436
New
51
Increased
634
Reduced
495
Closed
194
Top Buys
| 1 |
Invesco Senior Loan ETF
BKLN
|
+$392M |
| 2 |
Ares Management
ARES
|
+$226M |
| 3 |
SAP
SAP
|
+$219M |
| 4 |
Lam Research
LRCX
|
+$186M |
| 5 |
Apple
AAPL
|
+$158M |
Top Sells
| 1 |
KLA
KLAC
|
+$273M |
| 2 |
Toronto Dominion Bank
TD
|
+$247M |
| 3 |
AbbVie
ABBV
|
+$178M |
| 4 |
Intuit
INTU
|
+$109M |
| 5 |
Corebridge Financial
CRBG
|
+$99.7M |
Sector Composition
| 1 | Technology | 21.97% |
| 2 | Financials | 20.9% |
| 3 | Industrials | 10.1% |
| 4 | Healthcare | 9.35% |
| 5 | Consumer Discretionary | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Tower Semiconductor
TSEM
$7.54B
| $898K | ﹤0.01% |
17,314
+619
| +4% | +$32.1K |
|
1127
Prothena Corp
PRTA
$446M
| $896K | ﹤0.01% |
64,694
-36,000
| -36% | -$499K |
|
|
THRD
1128
DELISTED
Third Harmonic Bio
THRD
| $889K | ﹤0.01% |
86,396
+48,194
| +126% | +$496K |
|
1129
Peloton Interactive
PTON
$3.18B
| $853K | ﹤0.01% |
+98,000
| New | +$853K |
|
1130
Dropbox
DBX
$8.33B
| $844K | ﹤0.01% |
+28,100
| New | +$844K |
|
|
SLRN
1131
DELISTED
ACELYRIN
SLRN
| $840K | ﹤0.01% |
267,656
+93,276
| +53% | +$293K |
|
1132
Fortune Brands Innovations
FBIN
$7.11B
| $836K | ﹤0.01% |
12,234
+1,500
| +14% | +$102K |
|
1133
Entrada Therapeutics
TRDA
$199M
| $826K | ﹤0.01% |
47,788
| – | – |
|
1134
HDFC Bank
HDB
$182B
| $822K | ﹤0.01% |
+12,871
| New | +$822K |
|
|
CFB
1135
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $821K | ﹤0.01% |
54,164
-39,400
| -42% | -$597K |
|
1136
Keros Therapeutics
KROS
$621M
| $817K | ﹤0.01% |
+51,600
| New | +$817K |
|
1137
Knight Transportation
KNX
$6.78B
| $811K | ﹤0.01% |
15,294
+1,400
| +10% | +$74.3K |
|
1138
Xenon Pharmaceuticals
XENE
$2.87B
| $801K | ﹤0.01% |
20,430
| – | – |
|
1139
Tetra Tech
TTEK
$9.38B
| $782K | ﹤0.01% |
19,630
-23,200
| -54% | -$924K |
|
|
AZPN
1140
DELISTED
Aspen Technology Inc
AZPN
| $759K | ﹤0.01% |
3,042
+219
| +8% | +$54.7K |
|
1141
Nurix Therapeutics
NRIX
$692M
| $739K | ﹤0.01% |
39,234
-1,200
| -3% | -$22.6K |
|
1142
Axos Financial
AX
$5.22B
| $737K | ﹤0.01% |
10,548
-3,895
| -27% | -$272K |
|
1143
Neumora Therapeutics
NMRA
$269M
| $725K | ﹤0.01% |
68,418
-82,000
| -55% | -$869K |
|
|
FLG
1144
Flagstar Financial, Inc.
FLG
$5.28B
| $720K | ﹤0.01% |
77,168
| – | – |
|
1145
Albertsons Companies
ACI
$10.4B
| $713K | ﹤0.01% |
36,300
+5,100
| +16% | +$100K |
|
1146
Qorvo
QRVO
$8.09B
| $703K | ﹤0.01% |
10,047
-16,010
| -61% | -$1.12M |
|
1147
Custom Truck One Source
CTOS
$1.3B
| $702K | ﹤0.01% |
145,848
+35,800
| +33% | +$172K |
|
1148
Atkore
ATKR
$2.02B
| $701K | ﹤0.01% |
+8,400
| New | +$701K |
|
1149
Annexon
ANNX
$258M
| $686K | ﹤0.01% |
133,648
| – | – |
|
|
MBX
1150
MBX Biosciences, Inc. Common Stock
MBX
$365M
| $675K | ﹤0.01% |
36,600
-8,182
| -18% | -$151K |
|